Manometric: The 3D-printed braces that make a difference in people’s lives

Tailor-made hand braces and orthoses are expensive and not fully tailored to the needs of the person using them. Not to mention, they are not the most beautiful pieces out there. Pieter Smakman came across this problem during his graduation project at the TU Delft and together with his friend and colleague, Robin Jones, took on 3D scanning and printing technology to design and create braces that people love to wear. 

It didn’t take long until the two of them founded Manometric, a Delft-based startup looking to make the above possible for people who need a brace. 

FROM A SIMPLE IDEA

“We believe that braces are a consumer product and the experience of wearing them is more comparable to wearing a watch than a bandaid,” Pieter says. “It enables you to work again and perform your job. A piece of plastic can make a huge difference to someone’s life so it needs to fit the person him- or herself.”

During his Master’s in Integrated Product Design, Pieter came up with the idea of using 3D technology to create 360-scans of a hand and based on them, design a brace that is fully tailored to the person who needs it. The first version of the scanner was far from perfect, but it bore the potential of what it could become. 

“The first time we tried to scan a hand was not easy at all,” Pieter remembers. “Someone had to put their hand up and sit on a turning plateau in front of the 3D scanner so we could capture every angle. You can imagine how hard it is to keep a hand in a steady position even for a couple of seconds, so this was definitely not a very viable solution to collect information.”

Today, close to four years after founding Manometric, Pieter, Robin and their team have made leaps both in terms of their technology and in running a successful business. They are accredited as an orthopedic company, which enables them to see patients and work directly with health insurers. Even during COVID-19 times, they have been able to continue doing that – under strict measures, of course – and it is something that gives the team not only new insights for their research and development, but also a lot of positive energy. 

THROUGH YES!DELFT

Supporting them along the way has been the community of experts at YES!Delft and their international network. Manometric joined the YES!Delft Accelerator Program in September 2017 and quickly learned what it’s like to run a business. 

“The first thing we had to get into our system was to stop being so busy with our technology and instead focus on validating our product. We had to find out if there was a market for it before we spent more resources and effort developing it,” Pieter says.

Their mentor wasted no time in throwing them into the deep. “We were advised to organize a demo day, promote it on Facebook and see if people were willing to participate and pay for it. We went for it, but we were terrified,” Pieter remembers. “It just didn’t feel natural to promote a product that was not fully developed yet.” 

And while the two co-founders were surely outside of their comfort zone, they quickly saw the benefits of approaching their target market early on. They communicated their demo day to a large group of patients and were surprised to receive more than 150 responses overnight. Eventually, about 20 people signed up and traveled from all over the Netherlands to experience Manometric’s technology 

 “That meant a lot to us and it was the point where we knew we were onto something,” Pieter says. 

Those initial insights were what they needed to continue developing their technology. Today, the startup has a 3D scanner that can perform a 360 scan in a hundredth of a second, a software that can automate the production of orthoses and works together with hospitals, clinics, health insurers and other orthopedic companies. 

TO A GROWING COMPANY

Starting out, Pieter and Robin’s goal was to leverage technology in such a way that they could provide patients with the best-fitting hand braces possible, which look good too. At the same time, they also wanted to make the design and creation of those braces more efficient and less labor-intensive. 

“If you look at the traditional patient journey, there is a lot of time from intake to delivering the final product. With our 3D technology, we can achieve results much faster.”

Manometric has been working together with Gerald Kraan, an orthopedic surgeon from Reinier de Graaf hospital in Delft, who has helped them immensely over the past years. With his support, they have been able to develop their software and algorithms, and to make sure that the braces they create perform as well as traditional ones, if not even better.

The startup’s goal going forward is to have their scanners placed in hospitals all over the Netherlands. “Our solution is scalable and we can’t wait to distribute this widely,” Pieter says. 

The process may take some time, but the team has already proven that there is great potential for their technology, across the country and beyond. 

Having been able to disrupt (in a good way) such a traditional industry has certainly brought Pieter, Robin and their team the feeling that they can change people’s lives with their work. What makes it all even more worthwhile, though, is actually seeing the impact of their technology. 

“Not too long ago, one of our patients brought her saxophone to our office, sat down and started playing,” Pieter says. “It was the hand brace that we made for her that enabled her to play her instrument again. You can imagine the surprise on all of our faces.

It is those moments that count the most. It is those moments that remind us of the impact we can make.” 

Milestones of 2020

 

  • A doubling of the team (now 11) with highly talented and experienced people
  • More than tripled the revenue of 2019
  • Accredited as official Orthopedic Company
  • CE Certification for the ManoX 3D Scanner
  • Contracts with all Dutch health insurers

 

Don’t forget to apply for our next Accelerator Program, the application deadline is on the 31st of January.

Get to know more

Startups present their solutions at the Pitch Day of EIT Health Validation Lab

The EIT Health Pitch Day marked the end of this year’s EIT Health Validation Lab, and sent 17 early-stage MedTech startups into the market. The event was held entirely online on October 27 and gave teams a chance to pitch their innovation to our network. Lifelet Medical took the coveted first prize. 

“The Validation Lab was a great experience for Lifelet Medical, where we received excellent domain-specific mentorship and coaching. It was an honor to work with all of the startups, and we are delighted for the opportunity to advance to the central pitch competition and to accelerate our technology further”, says Elle Sander, co-founder of Lifelet Medical.

A partnership between EIT Health & YES!Delft

EIT Health Validation Lab is a partnership between YES!Delft and EIT Health. The two organizations join forces to offer early-stage companies an opportunity to validate their technology as best as possible, and combine YES!Delft’s startup expertise with the extensive knowledge and network of EIT Health. 

Over the course of eight weeks, the two parties provided the right tooling and coaching to startups to develop their skills to validate their riskiest business assumptions, to sharpen their problem-solution-fit, and find their product-market-fit. The Validation Lab is designed to help promising MedTech teams get in touch with mentors and industry specialists already early on. 

Solving a severe and relevant problem

Lifelet Medical, the winner of this edition, is on an ambitious yet very important mission. The team aims to improve the lives of patients with heart valve disease by developing fully synthetic durable and sustainable heart valve leaflets for life. 

“Lifelet is solving a severe problem that is very relevant worldwide, they have a unique innovation and an excellent team,” said Evert Jaap Lugt, Managing Director of YES!Delft, when he announced the startup as the winner. 

“We would like to thank all the startups and ecosystem partners for their ongoing enthusiasm throughout the program. I’m very curious to see what the future holds for these game-changers, I have very high expectations after everything we’ve seen so far”, says MedTech Program Manager, Claire Visser.

EIT Health Validation Lab

For 10 medtech startups, the EIT Health Validation Lab is over and the journey begins

The fifth edition of the EIT Health Validation Lab came to an end for 10 startups at YES!Delft this week. The Pitch Day marked the close of the two-month program and brought a number of highlights with it. The event, which welcomed more than 100 guests, gave a platform to all participating startups to pitch their business idea in front of a jury, with KroniKare emerging as the big winner and both Slam Ortho and VitalFlap as the runners-up. 

Over the course of eight weeks, the medtech startups got the opportunity to travel across the Netherlands and Europe to validate their business case. Meeting up with experts at leading universities, healthcare companies and hospitals such as Reinier de Graff in Delft, Haaglanden MC in The Hague, HealthValley Nijmegen and the Leiden Centre for Innovation and Entrepreneurship (PLNT), they tested the market potential of their ideas.

Kronikare, the winner of this edition, is a startup developing a wound scanner that uses AI to automate the process of wound assessment to just 30 seconds. By providing a real-time solution, the team hopes to give clinicians more time and less effort to improve their work. 

“It is brilliant how much the pitches improved since I saw the startups in our hospital just a few weeks ago,” said Marten van der Elst, one of the jury members, working at Reinier de Graaf. 

As the winner of the pitch competition, KroniKare will get a ticket to this year’s edition of the EIT Health Summit, which will take place on December 2-3 in Paris, France.

 

EIT Health Validation Lab is a partnership between YES!Delft and EIT Health and combines YES!Delft’s startup expertise with extensive knowledge and network of EIT Health. It is designed to help promising medtech teams validate their technology by working closely with mentors and industry specialists. The program is organized together with partners Biocat, LUMC, FAU, TU Delft, UMCG and University of Copenhagen

Innovation fund FundIQare invests in Momo Medical

Yes!Delft startup Momo Medical had an amazing announcement at yesterday’s Venture Café Rotterdam. FundIQare wants to support Momo Medical with a financial injection to expand the production capacity and scaling up the startup. They will also get the opportunity to further develop their technology in a living lab environment.

 

Momo Medical, founded in 2017, is an initiative of the young Delft entrepreneurs Ide Swager and Menno Gravemaker. They developed a tech solution for the prevention of pressure sores (decubitus ulcera) in elderly and chronically ill patients. The technology consists of a compact combination of sensors that can be used flexibly in beds. A sensor plate is placed underneath the mattress, which is connected to a control unit. The smart sensors and advanced algorithms map the client’s lying behavior and communicate it in a clear manner to health care professionals.

 

Momo Medical co-founder Menno used a soccer analogy to refer to their 19-month journey as a startup. “There is the saying in soccer that you always have to keep an eye on the ball. We believe there’s more to it because if you only have the eye on the ball you forget what the goal is and you lose sight of the people around you. And at the end of the game, you also need to reflect in order to learn.”

 

You can read the whole story of Momo Medical here and their press release here.

A successful launch for 10 Medtech startups

Delft, November 2, 2018 – LaunchDay marked the end of the two-month EIT Health Validation Lab program for 10 startups at YES!Delft on Thursday. Over the course of eight weeks, the teams traveled through the Netherlands and across Europe to validate the business potential of their ideas with leading universities, healthcare companies and hospitals. For example, the participants had visits to leading hospitals in the Netherlands, such as Radboud MC in Nijmegen, UMCG in Groningen, or Reinier de Graff in Delft where they connected with leading medical professionals to validate their solutions. Now that they have successfully concluded the program, they are ready to set out on a journey to conquer their target markets.

From enabling visually impaired people to process visual information around them, to diagnosing malaria through numerical algorithms, the startups each have a unique and pressing problem to solve in the medtech industry.

“The EIT Health Validation Lab, organized together with EIT Health, is a key opportunity for medtech teams to develop the potential of their technology and reach out to customers and partners, both in the Netherlands and abroad,” said Tjarda Voorneman, Special Projects Manager at YES!Delft. “This year’s edition was one of our strongest to date.”

As a partnership between YES!Delft and EIT Health, the EIT Health Validation Lab combines YES!Delft’s startup expertise with the extensive knowledge and network of EIT Health. It is designed to help promising medtech teams validate their technology by working closely with mentors and industry specialists.

From the 10 teams in the program, the winner is Smart Medical Optics. Their medtech solution is a low-cost, automated, smart malaria diagnostic device that is using numerical algorithms integrated into a smart imagining platform, which reduces diagnostic workload and provides efficient precision for accurate drug prescription. “Winning this only tells us that our product is well appreciated and we are taking it as a challenge, so that we ensure that this product gets to the people that really need it, in remote places in Africa, where there is no income, no resources, and no equipment,” said Temitope Agbana, co-founder of Smart Medical Optics. “We believe winning the program is a boost, a challenge, our call to action. We need to scale up our solution up bring it where this is really needed.”

The program is organised together with the program partners TU DelftLUMCBiocatTrinity DublinBioM and with the help of UMCGPLNT (Leiden)HealthValley, Reinier de Graaf and Radboud UMC.

***

There will be a next program starting in September 2019. If you happen to be a medtech startup or to know medtech startups, contact tjarda@yesdelft.nl. The Validation Lab is currently accepting applications for its next round. You can apply now!

Announcing the teams for EIT Health Bootcamp Launch Lab


 2018

The selected teams for EIT Health Bootcamp LaunchLab 2018

Eleven ambitious teams have been selected for the Bootcamp Launch Lab. We are proud to work on this program with EIT Health. The startups started their 8-week program today, 4th of September, in the Green House of our incubator.

The teams selected in the program are representing innovative ideas on solving or preventing health problems like impaired cognitive functions, parasitic infections or even mobility issues.

A unique program
EIT Health Bootcamp LaunchLab is a partnership between YES!Delft and EIT Health. It combines YES!Delft’s startup expertise and the extensive knowledge and network of EIT Health. It is designed to help promising medtech teams validate their technology by having access to trainings, mentors, and industry specialists.

The program is a unique two-month pressure cooker that allows aspiring entrepreneurs from all over Europe to discover the business potential in the med-tech area. The program is organised together with the partners TU Delft, LUMC, Biocat, Trinity Dublin, BioM, UMCG, PLNT (Leiden), HealthValley and Reshape Center (Radboud) Nijmegen.

Teams
Here are the participating teams: EIT health X YES!Delft Bootcamp Validation Lab 2018

Follow the teams and their progress on our website.

For questions about the program, contact Tjarda Voorneman or go to EIT Health x YES!Delft 2018 Team.

STIL

Giving Parkinson’s patients a steady hand

For most of us, carrying out routine tasks in our day-to-day lives may seem simple and effortless. Like having lunch and bringing a spoon from our bowl to our mouth. Or inserting a key into the keyhole of our front door. Yet, that isn’t the case for 45 million people worldwide, suffering from Essential Tremor or Parkinson’s Disease. For them, every attempt to do so is accompanied by the largely uncontrollable shaking of their hand, also known as tremors.

It is a problem that still needs an effective solution. Current treatments to suppress tremor are ineffective and have heavy side effects, causing patients to even reject treatment and live with the consequences.

STIL, a medtech startup co-founded by IJsbrand de Lange and Bastiaan van Gaalen, is looking to be that solution. The team is developing an anti-tremor brace that helps provide these patients with a steady hand by suppressing their involuntary shakes. The startup emerged as the winner of last year’s EIT Health Validation Lab (formerly LaunchLab), and as a result, has made strides in bringing its technology closer to the market.

The Validation Lab is a partnership between YES!Delft and EIT Health that combines YES!Delft’s startup expertise with the extensive knowledge and network of EIT Health.

 

Learn more about EIT Health Validation Lab

 

“As one of the top global business incubators, YES!Delft has developed a very strong entrepreneurship program for early stage entrepreneurs,” says Kurt Höller, Director of Business Creation at EIT Health. “For a second year in a row, this program opens for all European startups and is enriched by a European field trip to global players and excellent university hospitals among our EIT Health partners. There is no better way to find out if your business idea works.”

The program is specifically designed to help promising tech teams find their product-market fit, or rather their market-product fit, as Robert Jan van Vugt, Program Manager at YES!Delft, puts it.

The road to ‘creating a stable future’

For IJsbrand, the idea for STIL came about two years ago during his graduation project at the TU Delft, where he was researching new ways of suppressing tremors mechanically.

“I drew inspiration from noise cancelation technology, where two opposite sound waves cancel each other out and result in silence,” IJsbrand says. “My idea was to apply the same concept to mechanical vibrations, and use an ‘anti-vibration’ to counteract the tremor and such suppress it.”

He soon realized that his invention had quite some potential, as a lab test of the technology showed a 94% success rate in suppressing tremors.

It was an innovative concept that had to be brought to the market. IJsbrand applied for a Take-Off grant from the Dutch Organisation for Scientific Reseach (NWO) – and got it! – which allowed him to found STIL together with Bastiaan and work towards market validation.

Getting accepted in the EIT Health Validation Lab turned out to be a boost in the startup’s development, as during the two-month program, the founders got to discover the business potential of their idea, helped by top-notch universities, leading healthcare companies and world-class hospitals across Europe.

 

Learn more about EIT Health Validation Lab

 

They also learned that agility is key to running a startup. What the founders didn’t know at the beginning was that developing that specific medtech product would take years (and millions of euros) in clinical validation, putting market entry on hold for a while.

“There are currently no adequate treatments to suppress tremor,” IJsbrand says, “and patients need better options. They need them now.”

There was only one way forward: The founders had to rethink their business strategy, and they did so without having to give up on their ultimate goal.

They decided that in the short run, STIL will introduce their brace as a wellness device, selling it directly to customers and improving the technology based on the feedback they receive. In the long run, they will continue doing research and clinical validation until their product is fully ready to enter the medical market in Europe and the US.

IJsbrand and Bastiaan have learned that entrepreneurship can take you on a long and winding road, yet, what matters is to stay focused on your end goal. At the end of the day, it is people’s lives that can change for the better, and the two founders are working hard to make that happen.

 

Apply directly for EIT Health Validation Lab 2018!

MedTech

Momo Medical

Smart bed sensors that keep pressure ulcers to a minimum

Building a company is no easy task. Building a medical technology (MedTech) company – even less so. That, however, didn’t scare Ide Swager and Menno Gravemaker when they took it upon themselves to found Momo Medical. Their goal? To provide healthcare professionals with relevant and accurate data about patient mobility, thus helping them reduce the occurrence of pressure ulcers. Pressure ulcers and patient mobility? – we hear you asking. Not to worry, an explanation is on its way.

FROM A SIMPLE, YET AMBITIOUS CONCEPT
Ide has long been interested in the medical applications of electronics – as part of his Masters at the TU Delft, too – so for him, laying the foundation of his own MedTech business was a natural next step in his professional development. Menno, on the other hand, has been an entrepreneur ever since an early age, so the two were a perfect match for the start of Momo Medical.

And just like that, they set out to address the challenge of pressure ulcers. Pressure ulcers are a damage to the skin or underlying tissue as a result of pressure being exercised on them. “When sitting or lying, the bed or chair presses against your tissue and can damage the skin as well as the muscles underneath. This happens mostly near the bones,” Ide says.

The trouble with pressure ulcers is that they originate under the skin and are very difficult to diagnose – at least before they have burst open into a wound. “It’s a very complicated problem, because it depends on the person how fast those pressure ulcers develop,” Ide adds. “Sick people develop them faster, while severe patients can develop a first on-set within three hours. The tricky thing is that when you don’t see it, you don’t have a sense of urgency.”

This is exactly the problem the two MedTech entrepreneurs are looking to tackle: making pressure ulcers easier to prevent. They have, thus, developed a smart bed sensor that detects the position in which patients are lying in bed, and by on-going monitoring, provides healthcare professionals with relevant data to prevent pressure ulcers from emerging.

“We can couple our system with a hospital’s protocol and send an alert to the nurse call system when it’s time to reposition a patient,” Ide says. As a result, the risk of pressure ulcers can be decreased significantly.

TO BUILDING A GROWING COMPANY IN A YEAR
Momo Medical may have been around for just a year, yet they are already a team of 11, with a number of milestones to share. The reason for this quick start was, in part, the fact that Ide had previously worked at YES!Delft Students, and the network he built within YES!delft was ready to introduce Momo Medical to industry stakeholders.

 
Want to start your own MedTech startup as well? Join our Validation Lab!
 

By now the MedTech team has secured a number of subsidies, among which the STW Phase 1 grant and a smaller round of the Province of South Holland. What’s more, they have launched their first pilot with a Dutch hospital (Reinier de Graaf in Delft), nursing home (Pieter van Foreest) and the municipality of Delft.

“The pilot is a very important part of what we’re working on,” Ide says. “We’re setting up a long-term cooperation with the hospital that runs the pilot, so that could help us in the long run.” In March this year, the second phase of the pilot has started. The goal of this phase is to build the first clinical evidence, which is essential for getting a medical device on the market.

With plans to attract an investor in the near there is certainly a lot of hard work ahead of this MedTech company. In 2018 the major milestones are focused on pre-sales, medical device certification and design for manufacturing. Yet, it seems they know how to handle that just right.

MILESTONES
October 2015 – First idea conceptualized
November 2016 – Ide and Menno commit full-time to Momo Medical
February 2017 – Admission into YES!Delft’s Incubation Program
May 2017 – First pilot secured
June 2017 – Financing from STW Phase 1, MIT Haalbaarheid and
the Municipality of Delft secured
November 2017 – Started first pilot in hospital
December 2017 – Secured STW Phase 2 loan
February 2018 – Featured in Health~Holland Annual report
March 2018 – Pilot phase 2 starts, 10 devices operational

 

If you want to know more about our programs, you can find more information here. Or contact Emma Kluwen (startup scout) directly via email or phone +31628504045.

 

TBI and Corporate partners build startups at YES!Delft

Teams from TBI, Engie, Royal HaskoningDHV and KPN took the stage at YES!Delft on Wednesday to present their promising early stage startup ideas during LaunchDay. In this first corporate Validation Lab, employees from YES!Delft’s corporate partners, with TBI in the lead, paused their full-time jobs for a moment to find the best product-market fit for their innovative (corporate) startup ideas.

“Our teams were boosted by the startup environment and guidance offered by YES!Delft”, says Douwe van den Wall Bake, Manager Sustainable Development at TBI about the program the corporate teams followed.

Six teams from our corporate partners with innovative ideas joined the Validation Lab program 8 weeks ago. Because all of them also have a full time job, sessions were organized every other week. This way work and building a start-up can be combined. Validation Lab took the teams on a journey to validate their ideas and market potential, and find launching customers.

From an energy-neutral renovation plan for housing and in-the-cloud-repair of floor heating to prefab installation units for utility buildings. From a flexible and sustainable parking solution for construction sites and clean energy for harbor coasters to an app that helps you to never lose a thing anymore. Promising propositions were validated and worked out in an energetic environment with teams from different corporates helping each other out.

X-Decks

“Through the Validation Lab, we identified that 80% of inner city construction projects are eagerly awaiting our temporary and flexible parking solution called X-Decks”, says Validation Lab participant Hermen Jan van Ree from Royal HaskoningDHV. “Also, we validated that X-Decks physically fits most construction sites and that there are multiple viable business and earning models. Our validation journey even led to various promising leads for X-Decks.”

All the teams have successfully come up with a targeted customer segment and a clear value proposition. The startups all want to continue with their idea in one way or the other. “Temporarily taking teams out of the corporate environment changes their mind set and speeds up the innovation process”, says Robert Jan van Vugt, Program Manager of YES!Delft. “Therefore we believe programs like Validation Lab can be very helpful for corporates, as a part or a full replacement of their innovation program.”

More information about Validation Lab & Application

Medtech startup STIL wins second edition of EIT Health LaunchLab

Delft, November 3, 2017 – Medtech startup STIL, developing a solution for people with essential tremor, was announced the winner of the second EIT Health LaunchLab during Launchday at YES!Delft on Thursday. The Dutch team was one of the ten European startups selected for this unique two-month pressure cooker. The participants travelled all over Europe to discover the business potential of their idea, helped by top notch universities, leading healthcare companies and world-class hospitals.

“Winning is an unbelievable, overwhelming feeling. We’ve been working hard and we’re happy to see that the EIT Health ecosystem believes in our vision”, say STIL-founders Bastiaan van Gaalen and IJsbrand de Lange. “We’re now working towards the EIT Health summit and are preparing for our pilot study next year.”

A record number of hundred teams originally applied for the program, fifty of which pitched in front of the selection committee. “There were so many great teams that we’ve decided to launch a special new edition of the EIT Health Launchlab that will kick-off later this month”, says Program Manager Tjarda Voorneman. “We offer a unique network and the chance to launch your medtech startup in markets all over Europe. Ultimately helping to improve healthcare across Europe.”

Startup Journey
Early September, ten promising early-stage medtech teams from Europe started their startup-journey. Discovering the market potential for their ideas and designing the best business models took them on a trip from The Netherlands, Belgium and Germany to Sweden. It allowed them to speak to as many potential clients as possible and meet up with leading industry partners.

Partners such as BioM, Erasmus MC, Imec, RISE, TU Delft, Uppsala University and organisations like Medical Delta, LUMC, Roche and NLC made sure our participants moved fast forward with their exploration. The startup team that however validated their idea in the most efficient way was Hydrustents, working on a degradable stent.

LaunchDay, the grand finale of the EIT Health LaunchLab, however produced the ultimate winner of this edition on Thursday: STIL. Teams got the chance to showcase their ideas and progress in front of an audience of partners, investors and alumni of the program. The day was ended with a special Alumni Night, with former participants from all over the globe joining to share their knowledge and get inspired by the latest in medical technology.

About STIL
People with Essential Tremor have involuntary vibrations in the arms, making them unable to perform even the simplest tasks in life, such as eating and drinking. Current treatments have severe side-effects, causing patients to reject it and live with the consequences. STIL technology is capable of mechanically suppressing tremor and will provide a stable future for 30 million people worldwide. Watch the STIL pitch on YouTube.

Join us for Launchday of the next edition of EIT Health LaunchLab on December 20, 2017 – Register Here.

——-

About EIT Health LaunchLab
EIT Health LaunchLab is set up by EIT Health, together with incubator YES!Delft. With partners BioM, Erasmus MC, Imec, RISE, TU Delft, Uppsala University and with the support of many others like Medical Delta, LUMC, Roche and NLC. EIT Health is one of the largest healthcare initiatives worldwide and promotes entrepreneurship and innovates in healthy living and active ageing. The aim: improve quality of life and healthcare across Europe. More information on EIT Health LaunchLab, please visit the EIT Health website.

Contact: Tjarda Voorneman, Program Manager YES!Delft +31(0)614162722 tjarda@yesdelft.nl

  • 1
  • 2

Get weekly updates of YES!Delft startups and incubator news

Get in touch